Today’s M&A deals include announcements on Nurse.org, The Nursing Beat, Abacus Global Management, AccuQuote, Pandoblox, 3GC Group, Empatica, PKG Health, among others.
Nurse.org Acquires The Nursing Beat
Nurse.org has acquired The Nursing Beat, bringing together two powerhouse brands to create the largest online community for nurses. This strategic move aims to help nurses thrive in every stage of their career by providing breaking news, career tools, and resources. The acquisition enhances Nurse.org’s position as a leading platform for nursing news, education, and community engagement.
Abacus Global Management Acquires AccuQuote
Abacus Global Management (ABL) has announced the acquisition of AccuQuote, a premier online life insurance brokerage company. AccuQuote offers customers quotes from multiple insurance providers through a single platform. The acquisition provides strategic synergies and underscores Abacus’ commitment to building a holistic wealth approach for its clients.
Pandoblox Acquires 3GC Group
Pandoblox has acquired 3GC Group to integrate IT, cybersecurity, and data services into a unified enterprise platform. This strategic move aims to streamline operations and enhance governance, automation, and intelligence for clients, offering enterprise-grade solutions at a reduced cost. The acquisition leverages decades of experience in enterprise software and product development, enabling Pandoblox to deliver scalable infrastructure and execution capabilities without the traditional time, cost, or headcount requirements.
Empatica Acquires PKG Health
Empatica has acquired PKG Health to enhance its AI-enabled wearable technology with validated movement disorder algorithms. This acquisition strengthens Empatica’s position in neurology research, clinical care, and diagnostics by integrating PKG Health’s expertise in Parkinson’s disease monitoring. The combined platform aims to provide comprehensive digital endpoints for tremor and movement disorders, addressing the urgent demand for objective measures in clinical trials.
Thasniya VP
